Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB
Conditions
Tuberculosis, Multidrug-Resistant
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hospital Geral da Polana Caniço, Maputo, Mozambique
De La Salle Health Sciences Institute- DLSUMC, Dasmariñas, Philippines
Lung Center Of The Philippines, Quezon City, Philippines
Silang Specialists Medical Center, San Vincent Silang, Philippines
First Moscow State Medical University n.a. I.M. Sechenov, Moscow, Russia
THINK: Tuberculosis & HIV Investigative Network, Durban, South Africa
Sizwe Tropical Diseases Hospital, Johannesburg, South Africa
Wits Health Consortium, Port Elizabeth, South Africa
Desmond Tutu TB Centre, Stellenboch, South Africa
Makerere University Lung Institute, Kampala, Uganda
State Institute Of Phthisiology And Pulmonology N.A. F.G. Yanovskiy Of Ams Ukraine, Kiev, Ukraine
Study leads
Janssen Research & Development, LLC Clinical Trial
Study Director
Janssen Research & Development, LLC